Label Change for Viracept

On February 24, the FDA updated the Viracept (nelfinavir) label to include drug-drug interaction information between nelfinavir and wafarin (Coumadin).

Table 11 (Established and Other Potentially Significant Drug Interactions) of the Precautions section of the label was changed to add the following:

Coadministration of wafarin and Viracept may affect concentrations of wafarin. It is recommended that the INR (international normalized ratio) be monitored carefully during treatment with Viracept, especially when commencing therapy.

The complete, revised label will be posted soon at: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?CFID=55346468&CFTOKEN=9265aebc610f774b-8B7D07A4-9205-6A32-9603DBC8F183C3F4

The Friends of AIDS Foundation is dedicated to enhancing the quality of life for HIV positive individuals and empowering people to make healthy choices to prevent the spread of the HIV virus. To learn more about The Friends of AIDS Foundation, please visit: http://www.friendsofaids.org.


TOGETHER WE REMAIN STRONG!